Daré Bioscience, Inc. (DARE) Social Stream



Daré Bioscience, Inc. (DARE): $1.10

0.02 (+1.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DARE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Featured Post From StockTwits About DARE

$DARE It’s funny to see newbies in here so attached to the Gates grant. You can tell they chased the news and didn’t do their DD on the company.
LARC-1 is being designed to be an extremely low cost long term contraceptive. It’s purpose is to be obtainable for the poorest people on the planet. It’s been in design since 2013 l, it’s still in design stage. This is the 2nd grant from Gates foundation. If this device gets approval, the main contingency tied to it is that it “be made affordable to all”.
This is the least likely “catalyst” to get shareholder’s value.
Dare has much more juicy and current catalyst going on.
All these “smart” traders who chased Gates grant PR have no idea what they are investing in.
Sabrina said they will use the ATM to raise cash to take away some of their vulnerability when negotiating BV-1 commercialization agreement.
Who cares about the Gates grant. It’s a pet project and off the path of the yellow brick road.
The PR was used as a pump to raise $$$
JJ03, published August 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7687 seconds.